Podcast Episode 165: Navigating the New Era of Systemic Care in Atopic Dermatitis

Join us as Derek Chu, MD, PhD, explores the paradigm shift in treating atopic dermatitis as a systemic, immune-driven disease rather than a localized skin condition. We discuss the updates to the practice parameters including practical guidance on integrating of novel topicals, biologics, and JAK inhibitors into our treatment as well as the upcoming practice parameters on chronic spontaneous urticaria. 

To listen to the podcast episode, CLICK HERE.

If you have listened to the podcast and would like to receive CME, click on the Register tab and then complete the assessment.

Target Audience

  • Allergist/immunologists
  • Fellows-in-Training
  • Nurses and Nurse Practitioners
  • Physician Assistants and Other Allied Health Professionals

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Determine when to consider systemic therapy for atopic dermatitis, such as biologics and JAK inhibitors
  • Implement patient-centered management strategies that account for treatment adherence, patient preferences, and the mitigation of healthcare disparities in the long-term control of allergic skin diseases
  • Evaluate the latest evidence-based guidelines for chronic spontaneous urticaria (CSU), including the role of adjunct therapies and the integration of novel BTK inhibitors and biologics into the treatment algorithm
Summary
Available credit: 
  • 0.75 Attendance
    Attendance credit.
  • 0.75 CME
    CME credit.
Course opens: 
06/19/2026
Course expires: 
06/23/2027
Cost:
$0.00
Rating: 
0

The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All relevant financial relationships were mitigated by the planners, faculty, and reviewers prior to their participation in the development of this activity.
 

Planning Committee 

Rebecca R. Saff, MD PhD FAAAAI
Massachusetts General Hospital Allergy/Immunology Physician, Fellowship Program Director
Relevant Relationships: None

 
Faculty

Derek Kuo-Cheng Chu, MD PhD
McMaster University Assistant Professor, Clinical Immunology and Allergy
Relevant Relationships: None

Rebecca R. Saff, MD PhD FAAAAI
Massachusetts General Hospital Allergy/Immunology Physician, Fellowship Program Director
Relevant Relationships: None

 

AAAAI DISCLOSURE POLICY

Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:

  • Employment. Name of employer and job title.
  • Financial interests. All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
  • Research interests. All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
  • Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
  • Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
  • Gifts. All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
  • Other interests. All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.

The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.

ACCREDITATION STATEMENT

The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

DESIGNATION STATEMENT

The American Academy of Allergy, Asthma & Immunology designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CREDIT CLAIMING PERIOD

Credit claiming for this activity will expire at 11:59 pm on June 22, 2027. Requests to claim credit on or after June 23, 2027 will be subject to an administrative fee.

AAAAI PRIVACY POLICY

To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at [email protected].

QUESTIONS

Activity related questions should be directed to [email protected]. 

Available Credit

  • 0.75 Attendance
    Attendance credit.
  • 0.75 CME
    CME credit.

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari.  

Internet Explorer is no longer supported.